Wen-Min Chou

Title: The Innovative Contributions of Wen-Min Chou

Introduction

Wen-Min Chou is a notable inventor based in Miaoli, Taiwan. She has made significant contributions to the field of biotechnology, particularly in the development of methods to assess treatments for hepadnavirus infections. Her work is characterized by a strong focus on innovative solutions that address critical health challenges.

Latest Patents

Wen-Min Chou holds a patent for a "Recombinant HBV reporter system." This invention discloses a method for assessing the capacity of a substance to treat or prevent hepadnavirus infection. The system utilizes a reporter virus carrying genetic information for a first fragment of a recombinase and a reporter cell expressing a second fragment of the recombinase. When the reporter virus infects the reporter cell, the two fragments of the recombinase associate and excise a stop cassette that blocks the expression of a reporter gene. This innovative approach provides a valuable tool for evaluating potential treatments for hepadnavirus infections.

Career Highlights

Throughout her career, Wen-Min Chou has worked with prestigious institutions, including the Technical University of Munich and Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Wen-Min Chou has collaborated with notable colleagues such as Martin Mueck-Haeusl and Jochen Wettengel. These partnerships have further enhanced her research capabilities and expanded the impact of her work in the scientific community.

Conclusion

Wen-Min Chou's innovative contributions to biotechnology, particularly in the area of hepadnavirus treatment assessment, highlight her role as a leading inventor. Her patent and collaborations reflect her commitment to advancing health solutions through scientific research.